News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
05 24 2011 Second study in Obstetrics & Gynecology showcases OVA1's role in evaluating women with an ovarian massA paper published in the June issue of Obstetrics & Gynecology demonstrated that adding OVA1 to a physician's preoperative assessment...
-
05 23 2011 Quest Diagnostics Health Trends analysis of nearly 14 million allergy tests ranks "30 Worst Big Cities for Ragweed"Early results from the largest cross-sectional national allergy study ever conducted, to be released later this week, suggest that allergies have...
-
05 19 2011 Quest Diagnostics Incorporated (NYSE: DGX) today announced it has finalized an agreement to settle a previously disclosed civil lawsuit, brought by a...
-
05 17 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today the successful...
-
05 17 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its Board...
-
05 17 2011 Quest Diagnostics Health Trends™ Report also finds economically disadvantaged children tested for allergies at later agesEarly results from the largest cross-sectional national allergy study ever conducted, to be released later this month, demonstrate that food allergies...
-
05 12 2011 Obstetrics & Gynecology study also considers OVA1's place in future surgical referral guidelinesA study published online ahead of print in the June 2011 edition of Obstetrics & Gynecology demonstrated that American College of...
-
05 11 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled...
-
05 11 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, and Spark Acquisition...
-
05 09 2011 Quest Diagnostics Incorporated (NYSE: DGX) today announced it has reached an agreement in principle to settle a previously disclosed civil lawsuit,...
-
05 09 2011 National Sponsor of Society Initiative to Prevent Cancer-Related DeathsQuest Diagnostics, the world's leading provider of diagnostic testing, information and services (NYSE: DGX), today announced its national sponsorship of...
-
05 09 2011 Offer Concludes at 5 p.m. Tomorrow, Tuesday, May 10thQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark...
-
05 06 2011 Quest Diagnostics® (NYSE: DGX) today announced that Care360 user Paulo Andre, M.D., a neurologist in Framingham, MA, was the first Care360 EHR customer...
-
05 05 2011 First test from the Focus Diagnostics' Simplexa product line for the hospital-acquired infection (HAI) marketQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today...
-
05 04 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark...
-
05 03 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled...
-
05 03 2011 Over 52% of Fully-Diluted Shares Tendered to Date, Including Guaranteed SharesQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that Spark...
-
04 28 2011 Focus Diagnostics' Simplexa molecular tests on the 3M™ Integrated Cycler aid in detecting infectious disease viruses for organ transplant and other immunocompromised patientsQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today...
-
04 20 2011 - Total revenues of $1.8 billion, up 1%Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that for the first...
-
04 18 2011 Enters into Memorandum of Understanding Providing for the Settlement of Merger Agreement LitigationQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostics testing, information and services, announced today that, in...
-
04 18 2011 AccuType® IL28B test now available to physicians and for clinical trials researchQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced the...
-
04 13 2011 Quest Diagnostics Incorporated (NYSE: DGX) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as...
-
04 12 2011 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that it will...
-
04 06 2011 Simplexa™ molecular diagnostic test on the 3M™ Integrated Cycler wins bronze for best new product, science and medical diagnosticQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that the...
-
04 04 2011 Solidifies leadership in growing market for neurology diagnosticsQuest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced it has...